WASHINGTON, DC – FDA Commissioner Scott Gottlieb, M.D. posted a blog on Friday detailing the agency’s plans to implement the landmark 21st Century Cures Act, as well as updates on individual initiatives within the bill.
The #Path2Cures is paved by innovative, new technologies unleashing new treatments.
“The 21st Century Cures Act gave FDA many new authorities and resources to accomplish this mission,” wrote FDA Commissioner Gottlieb. “‘Cures’ provides FDA with tools aimed at modernizing our regulatory programs. The goal of many of these efforts is to make sure that we’re taking every appropriate step to facilitate access to safe and effective new innovation.”
“Seeing Cures come to fruition is life changing. For patients, it represents an unprecedented hope for the next wave of treatments that can help the sick and injured live better lives, or identify the key in unlocking the greatest medical maladies of our time,” said Energy and Commerce Committee Chairman Greg Walden (R-OR) and Rep. Fred Upton (R-MI). “This law will change the way we treat disease.”
Commissioner Gottlieb’s blog also details the scope of FDA’s Oncology Center of Excellence, and the Center for Biologics Evaluation and Research’s implementation of the regenerative medicine policies within the 21st Century Cures Act.
To view FDA’s implementation tracker of the 21st Century Cures Act, click HERE.